A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum

Abstract excerpt

BACKGROUND: Melanoma represents only 4% of all skin cancers, but nearly 80% of skin cancer deaths. This manuscript applies several new measurement technologies with the purpose of elucidating molecular signatures of melanoma aggressiveness. PURPOSE: We sought to determine whether low-abundant serum proteins related to apoptotic pathways could be measured and correlated with defined melanoma subtypes. Hydrogel...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell death mechanisms and regulation
• Share to Cutaneous Melanoma Detection and Management
• Share to Melanoma and MAPK Pathways